Inter-conversion of neuregulin2 full and partial agonists for ErbB4
- 14 December 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 364 (2), 351-357
- https://doi.org/10.1016/j.bbrc.2007.10.004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Activation of a Nuclear Factor κB/Interleukin-1 Positive Feedback Loop by Amphiregulin in Human Breast Cancer CellsMolecular Cancer Research, 2007
- Signaling through ERBB receptors: Multiple layers of diversity and controlCellular Signalling, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2β and agonist-independent coupling with downstream signalling eventsBiochemical Journal, 2006
- Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer InterfaceMolecular and Cellular Biology, 2005
- Phe45 of NRG2β is critical for the affinity of NRG2β for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2βGrowth Factors, 2005
- Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activationOncogene, 2002
- Cloning and Biological Activity of Epigen, a Novel Member of the Epidermal Growth Factor SuperfamilyOnline Journal of Public Health Informatics, 2001
- The role of EGF-related peptides in tumor growthFrontiers in Bioscience-Landmark, 2001
- Ligand Discrimination in Signaling through an ErbB4 Receptor HomodimerPublished by Elsevier BV ,2000